FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: diabetic autonomic neuropathy

Sort
E.g., 2013-05-25
E.g., 2013-05-25
Enter a comma separated list of user names.

(RTIX, CLNO, VCRT) PennyOmega.com Stocks in Action
Posted by pennylynnomega on April 19th, 2011

RTI Biologics (RTIX) has signed an agreement to provide spinal allograft implants to Alphatec Spine, Incorporated, which is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine.

Read More
comment 0
Share
Tags:
biomass, cleantech, Energy Security, clean electricity, cardiovascular disease, NASDAQ:RTIX, RTIX, Vicor Technologies, VCRT.OB, VCRT, diabetic autonomic neuropathy, Cleantech Transit, CLNO, CLNO.OB, OTC:CLNO, Phoenix Energy, Merced project, Alphatec Spine, arrhythmia, bovine tissue, cortical allograft, foreign energy, Heart Failure, human donated tissue, oil derivatives, OTC:VCRT, RTI Biologics, Section 1603, spinal allograft, spinal allograft implants, spine disorders, wood waste, xenograft implants

Vicor (VCRT.OB) Continues Expansion; Signs Distribution Agreement in Middle East
Posted by EmergingBiotechs on February 24th, 2011

Some companies just flutter around trying to strategize how to get operations rolling and others seem to have it all under control with continuously moving forward with operations, revenues and expansion. Vicor Technologies certainly qualifies as the latter of those two types. No catalyst is needed to keep the Company driving forward with advancements with their proprietary PD2i® technology.

Read More
comment 0
Share
Tags:
Vicor Technologies, VCRT.OB, VCRT, PD2i, PD2i Analyzer, diabetic autonomic neuropathy, Concussion Diagnostics, trauma diagnostics, Hadar Training and Medical Services

Vicor Technologies (VCRT.OB) Revenues Up with Increased Sales Force
Posted by EmergingBiotechs on February 19th, 2011

Vicor Technologies is branding their PD2i® technology as the “new vital sign” and, although that is not the primary use of the technology at this point, the PD2i Analyzer™ is growing rapidly in usage across the United States and showing up in the bottom line for the Company.

Read More
comment 0
Share
Tags:
Vicor Technologies, VCRT.OB, VCRT, PD2i, PD2i Analyzer, diabetic autonomic neuropathy, Concussion Diagnostics, trauma diagnostics

ADVERTISE WITH US